AC Immune to Host Key Opinion Leader Webinar on Alpha-Synuclein as a Target in Neurodegenerative Diseases
Webinar to take place on Tuesday, March 29th at 10:00 AM ET / 4:00 PM CET
AC Immune SA, a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, will host a key opinion leader (KOL) webinar on alpha-synuclein (a-syn) as a target in neurodegenerative diseases on March 29th at 10:00 AM ET / 4:00 PM CET.